Akalin et al identified risk factors for cytomegalovirus infection in recipients of renal and/or pancreatic transplant. These can help identify a patient who may benefit from higher dose or prolonged prophylaxis with ganciclovir or valganciclovir). The authors are from Mount Sinai School of Medicine in New York City.
Parameters:
(1) induction treatment
(2) CMV status of donor and recipient
(3) age of the patient
Parameter |
Finding |
Points |
induction treatment |
with thymoglobulin |
1 |
|
without thymoglobulin |
0 |
CMV status |
donor positive, recipient negative |
1 |
|
other |
0 |
age of the patient |
< 50 years |
0 |
|
>= 50 years |
1 |
number of risk factors =
= SUM(points for all 3 parameters)
Interpretation:
• minimum number of risk factors: 0
• maximum number of risk factors: 3
• The presence of either thymoglobulin induction or risky CMV status indicates a high risk patient.
• High risk patients may develop invasive CMV disease once prophylaxis is discontinued. These patient require higher doses and/or a longer period of prophylaxis (patients received either ganciclovir or valganciclovir). If infection does develop in a patient receiving prophylaxis, then resistance to the antiviral agent should be tested for.
Purpose: To evaluate a renal and/or pancreatic transplant who is at high risk for invasive CMV infection based on the study of Akalin et al.
Specialty: Infectious Diseases, Surgery, general
Objective: risk factors, adverse effects, comorbid conditions
ICD-10: B25,